HCID 178511956, compound → HCID 178511954, compound

HRID 1454560Notes

Reaction equation

HRID 1454560 reaction equation
[OH:1][C:2]1[C:7]([C:8]2[NH:12][C:11]3[CH:13]=[CH:14][C:15]([C:17]([NH2:19])=[NH:18])=[CH:16][C:10]=3[N:9]=2)=[CH:6][C:5]([S:20](=[O:33])(=[O:32])[NH:21][C:22](=[O:31])[CH2:23][CH2:24][C:25]2[CH:26]=[N:27][CH:28]=[CH:29][CH:30]=2)=[CH:4][C:3]=1[C:34]1[CH:39]=[CH:38][CH:37]=[C:36]([N+:40]([O-])=O)[CH:35]=1>FC(F)(F)C(O)=O.O=[Pt]=O>[NH2:40][C:36]1[CH:35]=[C:34]([C:3]2[CH:4]=[C:5]([S:20](=[O:33])(=[O:32])[NH:21][C:22](=[O:31])[CH2:23][CH2:24][CH:25]3[CH2:30][CH2:29][CH2:28][NH:27][CH2:26]3)[CH:6]=[C:7]([C:8]3[NH:12][C:11]4[CH:13]=[CH:14][C:15]([C:17]([NH2:19])=[NH:18])=[CH:16][C:10]=4[N:9]=3)[C:2]=2[OH:1])[CH:39]=[CH:38][CH:37]=1

Participants

4

Procedure

2-[2-Hydroxy-3′-nitro-5-(3-pyridin-3-yl-propionylsulfamoyl)-biphenyl-3-yl]-1H-benzoimidazole-5-carboxamidine (0.031 g, 0.05 mmol), prepared as in Example 10, was dissolved in trifluoroacetic acid (5 mL) and the solution was subjected to hydrogenation at 50 psi over PtO2 catalyst for 12 hours. The mixture was concentrated in vacuum and product was purified from the residue by reverse phase HPLC (acetonitrile gradient) to give 2-[3′-amino-2-hydroxy-5-(3-piperidin-3-yl-propionylsulfamoyl)-biphenyl-3-yl]-1H-benzoimidazole-5-carboxamidine (0.01 g). MS: found (M+H+) 562.4, (M−H+) 560.6, calc. 561.22.

Workup

  1. concentrationThe mixture was concentrated in vacuum and product
  2. customwas purified from the residue by reverse phase HPLC (acetonitrile gradient)

Sources & evidence

ORD record
ord-bbf7f64868f9439db11af8ed4092049d
Source dataset
uspto-grants-2009_01
Patent number
US07479502B2

Reaction notes

Loading…